• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人因子VIII相关抗原电泳迁移率的变化:亚基结构的证据

Changes in electrophoretic mobility of human factor VIII-related antigen: evidence for subunit structure.

作者信息

Ekert H, Chavin S I

出版信息

Br J Haematol. 1977 Jun;36(2):271-9. doi: 10.1111/j.1365-2141.1977.tb00648.x.

DOI:10.1111/j.1365-2141.1977.tb00648.x
PMID:301403
Abstract

Therapeutic factor-VIII concentrates were found to have factor VIII-related antigen (FVIIIRAg) with an electrophoretic mobility faster than that of plasma using two-dimensional crossed immunoelectrophoresis. Immediately after infusion of factor-VIII concentrates into patients, the electrophoretic mobility of FVIIIRAg in the patients' plasmas was increased to that of the antigen in the infused concentrates. Two hours after infusion, a proportion of the antigen had an electrophoretic mobility intermediate between that of the pre-infusion antigen and that of the concentrate antigen, and by 24 h after infusion the reversion of electrophoretic mobility to pre-infusion values was complete. The return of electrophoretic mobility to normal did not occur in vitro after 24 h. In vitro mixing experiments between pre-infusion plasma and concentrate resulted in antigen with a range of intermediate mobilities which were related to the relative proportions of slow and fast antigen in the mixture. In vitro mixing experiments with slow and fast antigen separated from intermediate purity factor VIII concentrate by agarose gel filtration resulted in the formation of a relatively large proportion of antigen with intermediate electrophoretic mobility. The most reasonable interpretation of the results is the formation of hybrids between the two electrophoretically different populations of antigen. This implies that VIIIRAg normally exists in a polymeric form which can spontaneously dissociate into the exist in equilibrium with a pool of partially and/or completely dissociated subunits.

摘要

采用二维交叉免疫电泳法发现,治疗性因子VIII浓缩物中的因子VIII相关抗原(FVIIIRAg)的电泳迁移率比血浆中的快。将因子VIII浓缩物注入患者体内后,患者血浆中FVIIIRAg的电泳迁移率立即升至注入浓缩物中抗原的迁移率。注入后两小时,一部分抗原的电泳迁移率介于注入前抗原和浓缩物抗原之间,注入后24小时,电泳迁移率完全恢复到注入前的值。24小时后,体外未出现电泳迁移率恢复正常的情况。注入前血浆与浓缩物的体外混合实验产生了一系列具有中间迁移率的抗原,这些迁移率与混合物中慢抗原和快抗原的相对比例有关。用琼脂糖凝胶过滤从中间纯度的因子VIII浓缩物中分离出的慢抗原和快抗原进行体外混合实验,结果形成了相对较大比例的具有中间电泳迁移率的抗原。对结果最合理的解释是两种电泳性质不同的抗原群体之间形成了杂交体。这意味着VIIIRAg通常以聚合物形式存在,该聚合物可自发解离成部分和/或完全解离的亚基池,并与之处于平衡状态。

相似文献

1
Changes in electrophoretic mobility of human factor VIII-related antigen: evidence for subunit structure.人因子VIII相关抗原电泳迁移率的变化:亚基结构的证据
Br J Haematol. 1977 Jun;36(2):271-9. doi: 10.1111/j.1365-2141.1977.tb00648.x.
2
Patterns of factor-VIII related antigen on crossed immunoelectrophoresis and large pore polyacrylamide gel-crossed immunoelectrophoresis in von Willebrand's disease.
Br J Haematol. 1980 Oct;46(2):269-76. doi: 10.1111/j.1365-2141.1980.tb05966.x.
3
Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.正常人和血管性血友病患者中凝血因子VIII促凝抗原及因子VIII相关抗原的凝胶过滤模式
Thromb Haemost. 1983 Aug 30;50(2):509-12.
4
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.血管性血友病因子对血浆中凝血因子VIII的稳定作用。关于输血后及解离的凝血因子VIII的研究以及血管性血友病患者的研究。
J Clin Invest. 1977 Aug;60(2):390-404. doi: 10.1172/JCI108788.
5
Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.抗血友病因子(因子VIII)性质的研究。关于正常血浆和血友病血浆中类似抗血友病因子抗原的进一步证据。
J Clin Invest. 1973 Sep;52(9):2191-7. doi: 10.1172/JCI107404.
6
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.正常因子VIII/血管性血友病因子蛋白的电泳异质性,以及血管性血友病患者的异常电泳迁移率。
J Lab Clin Med. 1976 Feb;87(2):185-94.
7
Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.新生儿脐带血中的凝血因子VIII促凝活性、凝血因子VIII相关抗原及血管性血友病因子
Br J Haematol. 1979 Aug;42(4):637-46. doi: 10.1111/j.1365-2141.1979.tb01176.x.
8
Type IIB von Willebrand's disease: unusual response to cryoprecipitate infusion.IIB型血管性血友病:对冷沉淀输注的异常反应。
Ann Intern Med. 1981 Jan;94(1):47-50. doi: 10.7326/0003-4819-94-1-47.
9
Antithrombin antigen of high molecular weight associated with neoantigen in hemophilic plasma after factor IX concentrate therapy.在凝血因子IX浓缩物治疗后,血友病血浆中与新抗原相关的高分子量抗凝血酶抗原。
Thromb Res. 1987 Jan 15;45(2):175-82. doi: 10.1016/0049-3848(87)90171-x.
10
Quantitation of binding of factor VIII antigen to concanavalin A.
Br J Haematol. 1981 Apr;47(4):607-15. doi: 10.1111/j.1365-2141.1981.tb02690.x.

引用本文的文献

1
Von Willebrand's disease: a clinical and molecular enigma. Twelfth Annual Paul M. Aggeler Memorial Lecture.血管性血友病:一个临床与分子层面的谜团。第十二届保罗·M·阿格勒纪念讲座。
West J Med. 1982 Apr;136(4):318-25.
2
Structural analysis of factor VIII antigen in von Willebrand disease.血管性血友病因子VIII抗原的结构分析
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6832-6. doi: 10.1073/pnas.77.11.6832.